Table 1 Content of collagen I/III and inflammatory factors in lung tissue (\(\overline{x}\pm \text{s}\), nā=ā6).
From: IL-17A regulates airway remodelling in COPD through the PI3K/AKT/mTOR pathway
Groups | Ad-LacZ | Ad-LacZ+3MA | Ad-IL-1β | Ad-IL-1β+3MA |
---|---|---|---|---|
Collagen I/GAPDH | 0.42ā±ā0.17 | 0.57ā±ā0.18 | 0.67ā±ā0.22* | 0.77ā±ā0.13*# |
Collagen III/GAPDH | 0.83ā±ā0.07 | 1.08ā±ā0.26* | 1.13ā±ā0.28* | 1.30ā±ā0.20*# |
IL-17A(pg/ml) by ELISA | 449.1ā±ā19.58 | 307.5ā±ā36.45* | 694.6ā±ā24.00* | 631.6ā±ā80.92 |
IL-17A(%Area)by IHC | 25.51ā±ā2.27 | 20.46ā±ā1.87* | 32.67ā±ā3.42* | 25.80ā±ā1.98 |
IL-6(pg/ml) by ELISA | 468.10ā±ā20.93 | 443.60ā±ā23.15 | 891.20ā±ā39.24* | 780.30ā±ā37.29* |
CCL20(pg/ml) by ELISA in Lung | 36.22ā±ā8.17 | 31.82ā±ā6.47 | 224.20ā±ā21.56* | 183.30ā±ā10.29* |
CCL20(pg/ml) by ELISA in plasma | 27.66ā±ā7.90 | 23.72ā±ā3.84 | 137.10ā±ā18.39* | 64.19ā±ā12.54* |